Bio-Techne Corporation (TECH) Declined on Weak Q4 Results

Bio-Techne Third Quarter 2024 Earnings: Beats Expectations

5 Stocks at the Forefront of S&P 500 ETF's Latest Rally

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024

BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)

Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ...

Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here’s Why.

Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate

Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges

Bio-Techne beats third-quarter estimates on improving demand for biotech products